Ovation Research Studies

Enroll Today in a Fertility Study

Ovation Fertility™ provides opportunities to enhance your chances for becoming pregnant while helping others at the same time. By enrolling in a fertility study, you help advance in-vitro fertilization success for all hopeful parents.

Current studies being offered within the Ovation Fertility network of IVF laboratories are investigating methods for selecting the best embryo, improving culture medium that nourishes an embryo, and validating a novel embryo incubator that includes a built-in microscope and camera.

  • All studies may not be available at all Ovation Fertility locations.
  • Potential participants may enroll in one study.

Please review the study information below to see if you qualify.


TiMMI Study 

The MIRI-TL™ is an embryo culture incubator using a built-in microscope and camera designed specifically for the continuous assessment of embryo development. After sperm fertilizes an egg, the IVF laboratory will grow the developing embryo in a Petri dish with a nourishing substance called culture medium. These are stored in carefully monitored and temperature controlled incubators.

The goal of this study is to compare the safety and effectiveness of the MIRI-TL compared to industry-standard incubators.

You may qualify for the TiMMI study if:

  • You are a woman using your own eggs.
  • You produce at least four normally fertilized eggs.
  • You will have intracytoplasmic sperm injection (ICSI) performed on the eggs.
  • You plan to pursue freeze-all IVF, pre-implantation genetic screening (PGS) or a fresh embryo transfer IVF cycle.
  • You are not currently enrolled in another study
  • This study is available in Austin, Texas

Patients who enroll, meet eligibility requirements and are randomly selected to have their embryos cultured in the MIRI-TL incubator will receive a video of all frozen or transferred embryos following the completion of their cycle. Limitations apply on the availability of space within the incubator.

Apply for this study >>


NXGeM Study 

This new embryo culture media formulation represents a minor modification of an existing FDA-cleared formulation for in vitro culture and does not appear to cause early degeneration/atresia of human embryos.

In the IVF lab, culture medium is the nutrient-rich substance that supports the growth of eggs, sperm and embryos. The goal of this study is to collect embryo development and pregnancy outcome data on embryos that are cultured in “second-generation” culture medium compared to industry-standard culture medium.

You may qualify for the NXGeM study if:

  • You are a woman using your own eggs.
  • You produce at least four normally fertilized eggs.
  • You will have intracytoplasmic sperm injection (ICSI) performed on the eggs.
  • You plan to pursue freeze-all IVF, pre-implantation genetic screening (PGS) or a fresh embryo transfer IVF cycle.
  • You are not currently enrolled in another study
  • This study is available in Austin and San Antonio, Texas

If you are chosen for this study, your embryos will be grown in both the treatment study group and the control group (standard medium culture).

Apply for this study >>


SeMS Study

Comparing two embryo selection methodologies—standard embryo grading versus individual embryo genetic profiles grading—for determining which genetically screened embryo to transfer in an IVF cycle.

The goal of this study is to determine the best method for selecting a genetically normal (euploid) embryo combined with the developmental grade. Empowered with this information, fertility patients and their physicians can choose to transfer a single embryo—the one with the highest probability for developing into a healthy baby.

You may qualify for the SeMS study if:

  • You undergo pre-implantation genetic screening (PGS).
  • You have at least two euploid, high-quality embryos.
  • You do NOT desire gender selection.
  • You do NOT need pre-implantation genetic diagnosis (PGD).
  • You agree to transfer only one embryo.
  • This Study is available in Austin and San Antonio, Texas; Newport Beach, CA; Las Vegas, NV; and Nashville, TN

Patients who enroll/meet eligibility will receive reimbursement for the thaw fee portion of their frozen-embryo transfer (FET).

Apply for this study >>